Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1921 1
1922 1
1923 2
1924 2
1963 2
1964 3
1965 1
1967 1
1970 3
1971 1
1972 1
1973 1
1975 2
1977 3
1978 3
1979 2
1980 4
1981 1
1982 2
1983 3
1985 4
1986 3
1987 4
1988 7
1989 3
1990 3
1991 7
1992 7
1993 12
1994 9
1995 9
1996 6
1997 11
1998 12
1999 17
2000 16
2001 8
2002 20
2003 13
2004 11
2005 17
2006 17
2007 17
2008 16
2009 25
2010 29
2011 45
2012 34
2013 41
2014 51
2015 52
2016 48
2017 44
2018 40
2019 31
2020 44
2021 47
2022 33
2023 36
2024 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

833 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: charlton mr. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J. Terrault NA, et al. Among authors: charlton m. Clin Gastroenterol Hepatol. 2023 Jul;21(8):2150-2166. doi: 10.1016/j.cgh.2023.04.005. Epub 2023 Apr 20. Clin Gastroenterol Hepatol. 2023. PMID: 37084928 Free article. Review.
Envisioning how to advance the MASH field.
Allen AM, Younossi ZM, Diehl AM, Charlton MR, Lazarus JV. Allen AM, et al. Among authors: charlton mr. Nat Rev Gastroenterol Hepatol. 2024 Oct;21(10):726-738. doi: 10.1038/s41575-024-00938-9. Epub 2024 Jun 4. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38834817 Review.
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh. Chalasani N, et al. Among authors: charlton m. Gastroenterology. 2012 Jun;142(7):1592-609. doi: 10.1053/j.gastro.2012.04.001. Epub 2012 May 15. Gastroenterology. 2012. PMID: 22656328 No abstract available.
Pharmacokinetics in sepsis.
Charlton M, Thompson JP. Charlton M, et al. BJA Educ. 2019 Jan;19(1):7-13. doi: 10.1016/j.bjae.2018.09.006. Epub 2018 Nov 9. BJA Educ. 2019. PMID: 33456848 Free PMC article. Review. No abstract available.
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis.
Noureddin M, Charlton MR, Harrison SA, Bansal MB, Alkhouri N, Loomba R, Sanyal AJ, Rinella ME. Noureddin M, et al. Among authors: charlton mr. Clin Gastroenterol Hepatol. 2024 Dec;22(12):2367-2377. doi: 10.1016/j.cgh.2024.07.003. Epub 2024 Jul 20. Clin Gastroenterol Hepatol. 2024. PMID: 39038768 Free article. Review.
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease.
Odenwald MA, Lin H, Lehmann C, Dylla NP, Cole CG, Mostad JD, Pappas TE, Ramaswamy R, Moran A, Hutchison AL, Stutz MR, Dela Cruz M, Adler E, Boissiere J, Khalid M, Cantoral J, Haro F, Oliveira RA, Waligurski E, Cotter TG, Light SH, Beavis KG, Sundararajan A, Sidebottom AM, Reddy KG, Paul S, Pillai A, Te HS, Rinella ME, Charlton MR, Pamer EG, Aronsohn AI. Odenwald MA, et al. Among authors: charlton mr. Nat Microbiol. 2023 Nov;8(11):2033-2049. doi: 10.1038/s41564-023-01493-w. Epub 2023 Oct 16. Nat Microbiol. 2023. PMID: 37845315 Free PMC article.
833 results